# Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma

> **NCT03695055** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Fujian Medical University** · enrollment: 60 (estimated)

## Conditions studied

- High-risk Aggressive Lymphoma After Auto-HSCT

## Interventions

- **DRUG:** Maintenance therapy post-HSCT

## Key facts

- **NCT ID:** NCT03695055
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2020-01
- **Final completion:** 2023-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03695055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03695055, "Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03695055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*